share_log

Piper Sandler Initiates Coverage On Unicycive Therapeutics With Overweight Rating, Announces Price Target of $9

Piper Sandler Initiates Coverage On Unicycive Therapeutics With Overweight Rating, Announces Price Target of $9

派珀·桑德勒以增持评级启动对Unicycive Therapeutics的报道,宣布目标股价为9美元
Moomoo 24/7 ·  04/04 07:03

Piper Sandler analyst Yasmeen Rahimi initiates coverage on Unicycive Therapeutics (NASDAQ:UNCY) with a Overweight rating and announces Price Target of $9.

派珀·桑德勒分析师亚斯敏·拉希米以增持评级启动了对Unicycive Therapeutics(纳斯达克股票代码:UNCY)的报道,并宣布目标股价为9美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发